The architecture of EGFR's basal complexes reveals autoinhibition mechanisms in dimers and oligomers

Area of Science:

• Cell Biology
• Structural Biology
• Biochemistry

Background:

• Current models of epidermal growth factor receptor (EGFR) autoinhibition rely on limited structural data and do not fully explain ligand-independent activation.
• Understanding EGFR regulation is crucial for targeted cancer therapies.

Purpose of the Study:

• To elucidate the structural mechanisms underlying EGFR autoinhibition and ligand-independent activation.
• To investigate the role of extracellular interactions in EGFR receptor assembly and signaling.

Main Methods:

• Utilized a combination of advanced imaging technologies and computational simulations.
• Analyzed receptor fragment structures and their assembly dynamics.

Main Results:

• Identified a novel extracellular head-to-head interaction forming ligand-free EGFR polymer chains.
• Demonstrated that this head-to-head interaction inhibits kinase-mediated dimerization.
• Observed that mutations or intracellular treatments disrupt polymers, leading to stalk-to-stalk dimers coupled to either active asymmetric or inactive symmetric kinase dimers.
• Challenged the prevailing view of the symmetric kinase dimer as the primary autoinhibitory species.

Conclusions:

• EGFR autoinhibition is primarily mediated by extracellular head-to-head polymer formation.
• Ligand-independent activation involves the disruption of these polymers and subsequent formation of specific dimer configurations.
• Dysregulated EGFR signaling involves a dynamic equilibrium of symmetric and asymmetric kinase dimers modulated by the C-terminal domain.